Wu, L., Yao, L., Zhang, H., Ouyang, T., Li, J., Wang, T., . . . Xie, Y. (2015). A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients. Oncotarget.
Chicago Stili AlıntıWu, Lina, et al. "A Genome-wide Association Study Identifies WT1 Variant With Better Response to 5-fluorouracil, Pirarubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Breast Cancer Patients." Oncotarget 2015.
MLA AlıntıWu, Lina, et al. "A Genome-wide Association Study Identifies WT1 Variant With Better Response to 5-fluorouracil, Pirarubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Breast Cancer Patients." Oncotarget 2015.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..